Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by LaserStock29on May 08, 2020 5:36pm
207 Views
Post# 31005454

RE:RE:TLT

RE:RE:TLT
wildkyd wrote:
That sure would be nice! 50 cents seems like a dream ...that was before we did that disastrous financing. I think my average is still .40 and that's after loading up on some cheap .20's. Still think we should be at $5.00 now. Maybe when we hear about 100% CR on 12 patients... Sky's the limit!



I love the constant flip flop...  for months.. the IND is bigger than the patient data.. then it switches.. back to the 6 month data..

multiple cans being kicked.

one thing is forsure.. there was loading done at .20.........  now was that for a flip at .40  or because finally after 6 years we get our 5x  and crack $1.00  on a true biotech pop because we enter the USA and that's all that matters.

ahhhh yeah.. lol

*sits back and waits* 

Bullboard Posts